Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion

Pharmacology Biochemistry and Behavior

Volumn 93, Issue 1, 2009, Pages 75-81

  Jones, Jermaine D ^c   Hall, F Scott ^b   Uhl, George R ^b   Rice, Kenner ^b   Riley, Anthony L ^a  

^a AMERICAN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Cocaine; Dopamine; Fluoxetine; Monoamine transporter; Nisoxetine; Norepinephrine; Preexposure; Serotonin; Taste aversion; Vanoxerine

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER; FLUOXETINE; NISOXETINE; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GAMMA RADIATION; LEARNING; MALE; MOUSE; NERVE ENDING; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; TASTE AVERSION;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING (PSYCHOLOGY); DOPAMINE; DOPAMINE UPTAKE INHIBITORS; FLUOXETINE; MALE; MICE; NOREPINEPHRINE; PIPERAZINES; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TASTE;

EID: 65549152188     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.04.009     Document Type: Article

References (61)

1. Baumann M.H., Phillips J.M., Ayestas M.A., Ali S.F., Rice K.C., and Rothman R.B. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence. Ann N Y Acad Sci 965 (2002) 92-108
2. Broadbent J., Muccino K.J., and Cunningham C.L. Ethanol-induced conditioned taste aversion in 15 inbred mouse strains. Behav Neurosci 116 (2002) 138-148
3. Cailhol S., and Mormède P. Conditioned taste aversion and alcohol drinking: strain and gender differences. J Stud Alcohol 63 (2002) 91-99
4. Cunningham C.L., Gremel C.M., and Groblewski P.A. Genetic influences on conditioned taste aversion. In: Reilly S., and Schachtman T.D. (Eds). Conditioned Taste Aversion: Behavioral and Neural Processes (2009), Oxford University Press, New York, NY 387-421
5. de Brugada I., Hall G., and Symonds M. The US-preexposure effect in lithium-induced flavor-aversion conditioning is a consequence of blocking by injection cues. J Exp Psychol Anim Behav Process 30 (2004) 58-66
6. de Ponti F. Pharmacology of serotonin: what a clinician should know. Gut 53 (2004) 1520-1535
7. Elkins R.L. Bait-shyness acquisition and resistance to extinction as functions of US preexposure prior to conditioning. Physiol Psychol 2 (1974) 341-343
8. Ettenberg A., and Geist T.D. Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology (Berl) 103 (1991) 455-461
9. Everitt B.J., and Hokfelt T. Neuroendocrine anatomy of the hypothalamus. Acta Neurochir 47 (1990) 1-15
10. Ferrari C.M., O'Connor D.A., and Riley A.L. Cocaine-induced taste aversions: effects of route of administration. Pharmacol Biochem Behav 38 (1991) 267-271
11. Ford K.A., and Riley A.L. The effects of LiCl preexposures on amphetamine-induced taste aversions: An assessment in blocking. Pharmacol Biochem Behav 20 (1984) 643-645
12. Fox M.A., Stevenson G.W., Rice K.C., and Riley A.L. Naloxone, not proglumide or MK-801, alters effects of morphine preexposure on morphine-induced taste aversion. Pharmacol Biochem Behav 84 (2006) 169-177
13. Freeman K.B., Rice K.C., and Riley A.L. Assessment of monoamine transporter inhibition in the mediation of cocaine-induced conditioned taste aversion. Pharmacol Biochem Behav 82 (2005) 583-589
14. Freeman K.B., Verendeev A., and Riley A.L. Noradrenergic antagonism enhances the conditioned aversive effects of cocaine. Pharmacol Biochem Behav 88 (2008) 523-532
15. Garcia J., Kimeldorf D.J., and Koelling R.A. Conditioned aversion to saccharin resulting from exposure to gamma radiation. Science 122 (1955) 157-158
16. Gommas J., Bouwknecht J.A., Hijzen T.H., Berendsen H.H., Broekkamp C.L., Maes R.A., et al. Stimulus properties of fluvoxamine in a conditioned taste aversion procedure. Psychopharmacology (Berl) 140 (1998) 496-502
17. Goudie A.J., Dickens D.W., and Thorton E.W. Cocaine-induced conditioned taste aversion in rats. Pharmacol Biochem Behav 8 (1978) 757-761
18. Grigson P.S. Conditioned taste aversions and drugs of abuse: a reinterpretation. Behav Neurosci 111 (1997) 129-136
19. Grigson P.S., and Freet C.S. The suppressive effects of sucrose and cocaine, but not lithium chloride are greater in Lewis than in Fischer rats: evidence for the reward comparison hypothesis. Behav Neurosci 114 (2000) 353-363
20. Grigson P.S., Lyuboslavsky P., and Tanase D. Bilateral lesions of the gustatory thalamus disrupt morphine- but not lithium chloride-induced intake suppression in rats: evidence against the conditioned taste aversion hypothesis. Brain Res 858 (2000) 327-337
21. Grigson P.S., Twining R.C., and Carelli R.M. Heroin-induced suppression of saccharin intake in water-deprived and water-replete rats. Pharmacol Biohem Behav 66 (2000) 603-608
22. Grill M., Sanna E., and Hanbauer I. Role of corticostriatal nerve projections in the regulation of binding site for dopamine uptake blockers. Soc Neurosci Abstr 14 (1988) 929
23. Hall F.S., Li X., Sora I., Xu F., Caron M., Lesch K.P., et al. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neurosci 115 (2002) 153-161
24. Hall F.S., Sora I., Drgonova J., Li X.F., Goeb M., and Uhl G.R. Molecular mechanism underling the rewarding effects of cocaine. Ann N Y Acad Sci 1025 (2004) 47-56
25. Heinrichs S.C., Britton K.T., and Koob G.F. Both conditioned taste preference and aversion induced by corticotropin-releasing factor. Phamacol Biochem Behav 40 (1991) 717-721
26. Holtzman S.G. Discriminative stimulus properties of caffeine in the rat: Noradrenergic mediation. J Pharmacol Exp Ther 239 (1986) 706-714
27. Howell L.L., and Bryd L.D. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in squirrel monkeys. J Pharmacol Exp Ther 258 (1991) 178-185
28. Huang A.C., and Hsiao S. Re-examination of amphetamine-induced conditioned suppression of tastant intake in rats: the task-dependent drug effects hypothesis. Behav Neurosci 122 (2008) 1207-1216
29. Hunt T., and Amit Z. Conditioned taste aversion induced by self-administered drugs: paradox revisited. Neurosci Biobehav Rev 11 (1987) 107-130
30. Hunt W.A., Spivak K., and Amit Z. Aversive stimulus properties of morphine: evaluation using the drug preexposure conditioned taste aversion paradigm. Behav Neural Biol 44 (1985) 60-73
31. Jones J.D., Busse G.D., and Riley A.L. Strain-dependent sex differences in the effects of alcohol on cocaine-induced taste aversions. Pharmacol Biochem Behav 83 (2006) 554-560
32. Koob G.F. Neural mechanisms of drug reinforcement. Ann N Y Acad Sci 654 (1992) 171-191
33. Kunin D., Smith B.R., and Amit Z. Cocaine and ethanol interaction in the conditioned taste aversion paradigm. Physiol Behav 67 (1991) 627-630
34. Kunin D., Bloch R.T., Smith B.R., and Amit Z. Caffeine, nicotine and mecamylamine share stimulus properties in the preexposure conditioned taste aversion procedure. Psychopharmacology (Berl) 159 (2001) 70-76
35. Lanteri C., Salomon L., Torrens Y., Glowinski J., and Tassin J.P. Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism. Neuropsychopharmacology 33 (2008) 1724-1734
36. LeBlanc A.E., and Cappell H. Attenuation of punishing effects of morphine and amphetamine by chronic prior pretreatment. J Comp Physiol Psychol 87 (1974) 691-698
37. Martin G.M., Bechara A., and van der Kooy D. Morphine preexposure attenuates the aversive properties of opiates without preexposure to the aversive properties. Pharmacol Biochem Behav 30 (1988) 687-692
38. Mokrani M.C., Duval F., Crocq M.A., Bailey P., and Macher J.P. HPA axis dysfunction in depression: correlation with monoamine system abnormalities. Psychoneuroendocrinology 22 Suppl 1 (1997) S63-S68
39. National Research Council. Guide for the case and use of laboratory animals (1996), National Academy Press, Washington, DC
40. National Research Council. Guide for the case and use of mammals in behavioral and neuroscience research (2003), National Academy Press, Washington, DC
41. Olivier B., Gommans J., van der Gugten J., Bouwknecht J.A., Herremans A.H., Patty T., et al. Stimulus properties of the selective 5-HT reuptake inhibitor fluvoxamine in conditioned taste aversion procedures. Pharmacol Biochem Behav 64 (1999) 213-220
42. Parker L.A. Taste reactivity responses elicited by cocaine-, phencyclidine-, and methamphetamine-paired sucrose solutions. Behav Neurosci 107 (1993) 118-129
43. Parker L.A. Rewarding drugs produce taste avoidance, but not taste aversion. Neurosci Biobehav Rev 19 (1995) 143-157
44. Prendergast M.A., Hendricks S.E., Yells D.P., and Balogh S. Conditioned taste aversions induced by fluoxetine. Physiol Behav 60 (1996) 311-315
45. Randall-Thompson JF. (2005) Characterization of dopamine and serotonin in concurrently conditioned taste aversion and place preferences. Dissertation Abstracts International.
46. Refahi-Lyman F., Saadauni S., Costentin J., and Bonnet J. Interaction of two sulfydryl reagents with a cation recognition site of the neuronal dopamine carrier evidences small differences between (H) GBR 12783 and (H) cocaine binding sites. Naunyn Schmiedebergs Arch Pharmacol 351 (1995) 136-145
47. Riley A.L., and Simpson G.R. The attenuating effects of drug preexposure on taste aversion conditioning: generality, experimental parameters, underlying mechanism and implications for drug use and abuse. In: Mower R.R., and Klein S.B. (Eds). Contemporary Learning Theory. 2nd Ed. (2001), Lawrence Erlbaum Associates, Hillsdale, NJ 505-559
48. Riley A.L., Davis C.M., and Roma P.G. Strain differences in taste aversion learning: implications for animal models of drug abuse. In: Reilly S., and Schachtman T.D. (Eds). Conditioned Taste Aversion: Behavioral and Neural Processes (2009), Oxford University Press, New York, NY 226-261
49. Roberts D.C. Self Administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats. Psychopharmacology 111 (1993) 202-206
50. Roberts D.C., Phelan R., Hodges L.M., Hodges M.M., Bennett B., Childers S., et al. Self-administration of cocaine analogs by rats. Psychopharmacology (Berl) 144 (1999) 389-397
51. Rocha B.A., Goulding E.H., O'Dell L.E., Mead A.N., Coufal N.G., Parsons L.H., et al. Enhanced locomotor, reinforcing and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J Neurosci 2 (2005) 10039-10045
52. Rothman R.B., and Glowa J.R. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development: focus on GBR 12909. Mol Neurobiol 11 (1995) 1-19
53. Rothman R.B., Blough B.E., Woolverton W.L., Anderson K.G., Negus S.S., Mello N.K., et al. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration. J Pharmacol Exp Ther 313 (2005) 1361-1369
54. Serafine K.M., and Riley A.L. Possible role of norepinephrine in cocaine-induced taste aversion. Pharmacol Biochem Behav 92 (2009) 111-116
55. Sora I., Hall F.S., Andrews A.M., Itokawa M., Li X.F., Wei H.B., et al. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci U S A 98 (2001) 5003-5005
56. Tella S.R. Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol Biochem Behav 5 (1995) 687-692
57. Wilson J.M., Norbrega J.N., Carrol M.E., Niznik H.B., Shannak K., Lac S.T., et al. Heterogenous subregional binding patterns of H-WIN 35,328 and H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci 14 (1994) 2966-2979
58. Xu M., Guo Y., Vorhees C.V., and Zhang J. Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Res 852 (2000) 198-207
59. Yamashita M., Fukushima S., Shen H.W., Hall F.S., Uhl G.R., Numachi Y., et al. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. Neuropsychopharmacology 31 (2006) 2132-2139
60. Yang X.M., Gorman A.l., Dunn A.J., and Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies of. Pharmacol Biochem Behav 41 (1992) 643-650
61. Zhou. Norepinephrine transporter inhibitors and their therapeutic potential. Drugs Future 29 (2004) 1235-1244